About Covaris
Covaris is a Healthcare company based in Woburn (United States) founded in 1998 by Jim Laugharn, and was acquired by PerkinElmer in December 2023. Sample preparation platforms using ultrasonic acoustics. Its chief executive, as recorded, is Jim Laugharn. Its website covaris.com draws about 18 thousand monthly visits. Covaris offers products and services including S220 Instrument, truCOVER Kits, M220 Instrument, and truXTRAC Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its legal entity is COVARIS, INC. Its competitors include Quanterix, Biocare Medical and BioLife Solutions; 2 of its 3 listed competitors have raised funding.
Company details
Covaris develops and manufactures ultrasonicators and other sample preparation platforms for life sciences research based on its proprietary and patented Adaptive Focused Acoustics (AFA) technology. AFA uses controlled and focused bursts of ultrasonic acoustic energy to a discrete zone within a sample vessel immersed in a water bath to mechanically process the sample. The versatility in power settings supports a wide variety of applications, from gentle mixing to DNA shearing, tissue disruption, and compound management including dissolution, formulation, and emulsification. These acoustic processes are performed in an isothermal, non-contact environment the water bath maintains sample temperature, and only acoustic energy enters the sample vessel. Apart from sonicators for specific applications and throughputs, the company also makes the cryoPREP Extraction Systems that integrate the tissue processing workflow from point-of-collection flash freezing to biochemical extraction with AFA Focused-ultrasonicators. Covaris also manufactures kits and reagents for ChIP, cfDNA extraction, FFE DNA and RNA extraction, sample collection kits, DNA and protein extraction kits, DNA shearing verification kits, etc. Covaris ultrasonicators are recommended by Illumina for library preparation for their NGS instruments.
- Headquarters Woburn, United States
- Founders Jim Laugharn
- Stage Acquired
- SectorsHealthcare
- Website covaris.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by New Mountain Capital (Jan 2021)
- Legal Name Covaris, Inc
- Latest Funding Round$414.93K (USD), Grant
May 2019
- InvestorsHHS
& 2 more
- Acquired by
Products & Services of Covaris
Covaris offers a comprehensive portfolio of products and services, including S220 Instrument, truCOVER Kits, M220 Instrument, and truXTRAC Kits.
High power device for single tube sample preparation
PCR-free kits for whole genome sequencing applications
Standard tool for single tube processing in research
Kits for FFPE biomolecule extraction and processing
Apps and channels of Covaris
its YouTube channel Covaris, LLC has 14.9K subscribers and 30 videos.
Videos from Covaris
The most watched videos on Covaris's YouTube channel, Covaris, LLC (14.9K subscribers). Click a video to play it here.
More on Covaris, LLC.
Funding Insights of Covaris
- Total Rounds 6
- Last Round Grant — $414,926
- First Round $1.66M
(Sep 2014)
- Investors Count 1
All 6 funding rounds of Covaris with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Covaris
Covaris has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, PerkinElmer and New Mountain Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
New Mountain Capital manages investments in private equity, credit, and net lease strategies. | newmountaincapital.com | |||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Medical instruments and supplies are manufactured and provided for healthcare. | 1931 | perkinelmer.com | Waltham, United States |
Investor details for Covaris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Covaris
58 people are tracked at Covaris (34 in leadership, 1 in board & advisors, 23 in team).
| Name | Role | Group |
|---|---|---|
Jim Laugharn | Founder & CEO | Leadership |
Justin Laurenzo | Vice President | Leadership |
Joshua B. Porter | Managing Director | Leadership |
John R. Kline | President & Chief Operating Officer | Leadership |
Shiraz Y. Kajee | Chief Financial Officer, Managing Director | Leadership |
Laura C. Holson | Chief Operating Officer | Leadership |
Robert A. Hamwee | CEO | Leadership |
Ivo Turkedjiev | Managing Director | Leadership |
Hillel Lehmann | Vice President & Operating Partner | Leadership |
Michael Rotondo | Vice President | Leadership |
Diana Thomas | Director, Controller | Leadership |
Jack Qian | Managing Director | Leadership |
William Murphy | Director | Leadership |
Joseph W. Hartswell | Chief Compliance Officer & Corporate Secretary | Leadership |
Andrew B. | Managing Director And Business Executer - New Mountain Capital Japan GK | Leadership |
Ray Thaler | Director & Operating Partner | Leadership |
Stephanie Slaven | Vice President | Leadership |
Vaibhav Gupta | Director And Operating Partner | Leadership |
Jag Buddhavarapu | Vice President | Leadership |
Tyler Saitta | Director - Operating Partner | Leadership |
38 more people are available in the full profile.
Complete people profiles for Covaris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Covaris
5 dated milestones of Covaris across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Covaris is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Grant, of $415K.
- Exit Acquired by New Mountain Capital.
- Exit Acquired by PerkinElmer.
Competitors of Covaris
Covaris has 3 listed competitors in our database, 2 of them funded. They include Quanterix, Biocare Medical and BioLife Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. |
Detailed competitors of Covaris
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Covaris
The website of Covaris (covaris.com) receives about 18.2K visits a month.
- Monthly visits18.2K
▼ 9.5% vs previous month
Websites whose visitors overlap most with Covaris. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ogt.com | 100% | 18K | #1,453,089 | View details | |
| sptlabtech.com | 100% | 23.8K | #1,239,423 | View details | |
gtbiotech.com.tw | gtbiotech.com.tw | 95% | #10,397,429 | – | |
covarisinc.com | covarisinc.com | 92% | – | ||
| novogene.com | 76% | 366.1K | #104,051 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Covaris
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Covaris (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Covaris
Complete news archive for Covaris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Covaris
Covaris was founded in 1998 and raised its 1st funding round 16 years after it was founded.
Covaris is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Jim Laugharn is the CEO of Covaris, as recorded in our data. They have also founded this company.
Covaris develops and manufactures ultrasonicators and other sample preparation platforms for life sciences research based on its proprietary and patented Adaptive Focused Acoustics (AFA) technology. AFA uses controlled and focused bursts of ultrasonic acoustic energy to a discrete zone within a sample vessel immersed in a water bath to mechanically process the sample. The versatility in power settings supports a wide variety of applications, from gentle mixing to DNA shearing, tissue disruption, and compound management including dissolution, formulation, and emulsification. These acoustic processes are performed in an isothermal, non-contact environment the water bath maintains sample temperature, and only acoustic energy enters the sample vessel. Apart from sonicators for specific applications and throughputs, the company also makes the cryoPREP Extraction Systems that integrate the tissue processing workflow from point-of-collection flash freezing to biochemical extraction with AFA Focused-ultrasonicators. Covaris also manufactures kits and reagents for ChIP, cfDNA extraction, FFE DNA and RNA extraction, sample collection kits, DNA and protein extraction kits, DNA shearing verification kits, etc. Covaris ultrasonicators are recommended by Illumina for library preparation for their NGS instruments.
Covaris's top competitors include Biocare Medical, Quanterix and BioLife Solutions.
Covaris offers S220 Instrument, truCOVER Kits, M220 Instrument, and truXTRAC Kits.
Covaris has 3 investors. Key investors include HHS, PerkinElmer, and New Mountain Capital.
Covaris operates through Covaris, Inc.
Yes. Covaris was acquired by New Mountain Capital in January 2021.